Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer - PubMed (original) (raw)
. 2011 Sep 1;71(17):5678-87.
doi: 10.1158/0008-5472.CAN-11-0431. Epub 2011 Aug 16.
Affiliations
- PMID: 21846823
- DOI: 10.1158/0008-5472.CAN-11-0431
Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer
Ludovic Martinet et al. Cancer Res. 2011.
Abstract
The mechanisms governing infiltration of lymphocytes into tumors remain poorly characterized, in spite of the critical impact of these cells on patient prognosis and therapeutic responses. High endothelial venules (HEV) are blood vessels found in lymphoid tissues, specialized in lymphocyte recruitment, but their implications in human cancer are unknown. In this article, we report the presence of MECA 79(+) blood vessels displaying all the phenotypic characteristics of HEVs in most of the 319 human primary solid tumors, including melanomas, breast, ovarian, colon, and lung carcinomas, analyzed. Tumor HEVs were specifically located within lymphocyte-rich areas, and their density within the tumor stroma was a strong predictor of infiltration by CD3(+) and CD8(+) T cells as well as B cells. Large-scale flow cytometric and quantitative reverse transcriptase-PCR analyses in freshly operated breast tumors revealed that high densities of tumor HEVs correlated with increased naive, central memory and activated effector memory T-cell infiltration and upregulation of genes related to T-helper 1 adaptive immunity and T-cell cytotoxicity. Finally, in a retrospective cohort of 146 invasive breast cancer patients, we found that high densities of tumor HEVs independently conferred a lower risk of relapse and significantly correlated with longer metastasis-free, disease-free, and overall survival rates. Together, our findings suggest that tumor HEVs function as major gateways for lymphocyte infiltration into human tumors, and may represent attractive targets for cancer diagnosis and therapy.
©2011 AACR.
Similar articles
- High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer.
Martinet L, Filleron T, Le Guellec S, Rochaix P, Garrido I, Girard JP. Martinet L, et al. J Immunol. 2013 Aug 15;191(4):2001-8. doi: 10.4049/jimmunol.1300872. Epub 2013 Jul 3. J Immunol. 2013. PMID: 23825314 - High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes.
Martinet L, Le Guellec S, Filleron T, Lamant L, Meyer N, Rochaix P, Garrido I, Girard JP. Martinet L, et al. Oncoimmunology. 2012 Sep 1;1(6):829-839. doi: 10.4161/onci.20492. Oncoimmunology. 2012. PMID: 23162750 Free PMC article. - High endothelial venules in intracranial germinomas: Implications for lymphocytes infiltration.
Chen H, Li G, Cui Y, Zhang Q, Li B, Liu X. Chen H, et al. Cancer Med. 2023 Mar;12(5):5450-5460. doi: 10.1002/cam4.5367. Epub 2022 Oct 19. Cancer Med. 2023. PMID: 36259639 Free PMC article. - High endothelial venules (HEVs) in immunity, inflammation and cancer.
Blanchard L, Girard JP. Blanchard L, et al. Angiogenesis. 2021 Nov;24(4):719-753. doi: 10.1007/s10456-021-09792-8. Epub 2021 May 6. Angiogenesis. 2021. PMID: 33956259 Free PMC article. Review. - High endothelial venules in cancer: Regulation, function, and therapeutic implication.
Vella G, Hua Y, Bergers G. Vella G, et al. Cancer Cell. 2023 Mar 13;41(3):527-545. doi: 10.1016/j.ccell.2023.02.002. Epub 2023 Feb 23. Cancer Cell. 2023. PMID: 36827979 Review.
Cited by
- Tertiary Lymphoid Structures and Immunotherapy: Challenges and Opportunities.
Ruddle NH. Ruddle NH. Methods Mol Biol. 2025;2864:299-312. doi: 10.1007/978-1-0716-4184-2_16. Methods Mol Biol. 2025. PMID: 39527229 Review. - Automated Quantification of Tertiary Lymphoid Structures in Human Tumor Samples Using Immunofluorescence and AI-Powered Analysis Pipeline.
Ghamry-Barrin S, Dieu-Nosjean MC, Panouillot M. Ghamry-Barrin S, et al. Methods Mol Biol. 2025;2864:205-229. doi: 10.1007/978-1-0716-4184-2_11. Methods Mol Biol. 2025. PMID: 39527224 - Maturation of Tertiary Lymphoid Structures.
Shu DH, Sidiropoulos DN. Shu DH, et al. Methods Mol Biol. 2025;2864:43-55. doi: 10.1007/978-1-0716-4184-2_3. Methods Mol Biol. 2025. PMID: 39527216 Review. - Spatial multiplexed immunofluorescence analysis reveals coordinated cellular networks associated with overall survival in metastatic osteosarcoma.
Lacinski RA, Dziadowicz SA, Melemai VK, Fitzpatrick B, Pisquiy JJ, Heim T, Lohse I, Schoedel KE, Llosa NJ, Weiss KR, Lindsey BA. Lacinski RA, et al. Bone Res. 2024 Sep 27;12(1):55. doi: 10.1038/s41413-024-00359-z. Bone Res. 2024. PMID: 39333065 Free PMC article. - Targeting the tumour vasculature: from vessel destruction to promotion.
Guelfi S, Hodivala-Dilke K, Bergers G. Guelfi S, et al. Nat Rev Cancer. 2024 Oct;24(10):655-675. doi: 10.1038/s41568-024-00736-0. Epub 2024 Aug 29. Nat Rev Cancer. 2024. PMID: 39210063 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials